Results 231 to 240 of about 144,032 (247)

Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides

Expert Opinion on Drug Metabolism and Toxicology, 2019
Rosie Yu, Richard Geary, Scott P Henry
exaly  

Inhibition of microRNA with antisense oligonucleotides

Methods, 2008
Christine C Esau
exaly  

Antisense Pharmacodynamics: Critical Issues in the Transport and Delivery of Antisense Oligonucleotides

Pharmaceutical Research, 1999
Rudy Juliano, Suresh K Alahari, R Kole
exaly  

Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats

Kidney International, 2003
Takehiko Koji, Masanobu Miyazaki, Akira Furusu   +2 more
exaly  

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

Journal of Clinical Medicine, 2020
Karishma Mohan Dhuri, Elias Quijano, Anisha Gupta   +2 more
exaly  

Review on investigations of antisense oligonucleotides with the use of mass spectrometry

Talanta, 2018
Sylwia Studzińska
exaly  

Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides

Journal of Drug Targeting, 2013
Rudy Juliano
exaly  

Novel non-endocytic delivery of antisense oligonucleotides

Advanced Drug Delivery Reviews, 2000
Yon Rojanasakul
exaly  

LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model

Molecular Therapy - Nucleic Acids, 2017
Vedad Delic, Andreas Weihofen, Eric E Swayze   +2 more
exaly  

Antisense oligonucleotides in cutaneous therapy

Pharmacology & Therapeutics, 2001
Paul J White, Christopher J Wraight
exaly